Petaluma, Calif.’s Oculus Innovative Sciences, which makes wound care and infection prevention products, priced its initial public offering of 3 million shares at $8 per share, the low end of its planned range of $8 to $10.

The company will be traded under the ticker “OCLS” on the Nasdaq.

(Originally posted 1/25)

VentureBeat

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform
  • networking features, and more
Become a member